Amgen
AMGN
1,887 hedge funds and large institutions have $90.9B invested in Amgen in 2019 Q1 according to their latest regulatory filings, with 127 funds opening new positions, 722 increasing their positions, 804 reducing their positions, and 113 closing their positions.
12% more first-time investments, than exits
New positions opened: 127 | Existing positions closed: 113
0% less funds holding
Funds holding: 1,892 → 1,887 (-5)
0.49% less ownership
Funds ownership: 77.6% → 77.11% (-0.49%)
4% less capital invested
Capital invested by funds: $95.2B → $90.9B (-$4.25B)
10% less repeat investments, than reductions
Existing positions increased: 722 | Existing positions reduced: 804
47% less funds holding in top 10
Funds holding in top 10: 134 → 71 (-63)
50% less call options, than puts
Call options by funds: $783M | Put options by funds: $1.58B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$268M |
| 2 |
D.E. Shaw & Co
New York
|
+$212M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$153M |
| 4 |
Legal & General Group
London,
United Kingdom
|
+$138M |
| 5 |
State Street
Boston,
Massachusetts
|
+$128M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.48B |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$334M |
| 3 |
Capital International Investors
Los Angeles,
California
|
-$314M |
| 4 |
Morgan Stanley
New York
|
-$241M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$197M |
AMGN Hedge Fund Activity: Q1 2019 in Review
1,887 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q1 2019, worth a combined $90.9B — down 4.5% from $95.2B a quarter earlier.
Buyers outnumbered sellers: 127 funds opened new AMGN positions and 113 closed out — a net gain of 14 holders — while 722 added to existing stakes and 804 trimmed.
The largest buyer was Wells Fargo, adding an estimated $268M. The largest seller was Fidelity Investments, cutting an estimated $1.48B.
- 1,887 institutional investors held Amgen (AMGN) as of Q1 2019, down from 1,892 in Q4 2018.
- Funds reported $90.9B of Amgen stock for Q1 2019, down 4.5% quarter-over-quarter.
- 127 funds opened new Amgen positions in Q1 2019 and 113 closed out, a net change of +14 holders.
- The largest Amgen buyer in Q1 2019 was Wells Fargo, an estimated $268M added.
- The largest Amgen seller in Q1 2019 was Fidelity Investments, an estimated $1.48B sold.
Based on aggregated 13F filings for Q1 2019.